课题基金 / 基金详情

SYNTHESIS AND TESTING OF MALE CONTRACEPTIVE AGENTS

SYNTHESIS AND TESTING OF MALE CONTRACEPTIVE AGENTS
男性避孕药的合成与测试
批准号:
2315185
负责人:
LUDWIG BAUER
金额:
$16.42万
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-03-01 至 1996-01-31

项目摘要

项目成果

LUDWIG BAUER的其他基金

相似基金

相关文献

中文摘要
翻译
这项建议的长远目标是发展一个安全的非- 激素口服男性避孕药,具有睾丸后作用模式。 该建议是基于观察到酮康唑,一种安全的口服 人类杀真菌剂导致,导致精子射精, 无法动弹 对大鼠施用酮康唑使其 不能生育 基于酮康唑(1)的结构,其为N- 取代的1(H)-咪唑,建议合成一系列 类似的C-取代的咪唑(2)用于评价。
英文摘要
The long-term objective of this proposal is to develop a safe non- hormonal oral male contraceptive that has post-testicular mode of action. The proposal is based on the observation that ketoconazole, a safe oral human fungicide causes, causes ejaculation of spermatozoa which are immobilized. Administration of ketoconazole to rats renders them infertile. Based on the structure of ketoconazole (1), which is a N- substituted 1 (H)-imidazole, it is proposed to synthesize a series of analogous C-substituted imidazoles (2) for evaluation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SYNTHESIS AND TESTING OF MALE CONTRACEPTIVE AGENTS
SYNTHESIS AND TESTING OF MALE CONTRACEPTIVE AGENTS
SYNTHESIS AND TESTING OF MALE CONTRACEPTIVE AGENTS
SYNTHESIS AND TESTING OF MALE CONTRACEPTIVE AGENTS
海外基金